To the full analysis
Buyback calculator for Fortis Healthcare
Fortis Healthcare stock: key metrics
FORTIS.NSFortis Healthcare had an operating margin of 17.9% and a return on invested capital (ROIC) of 10.5% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2007 | 65.4% | −4.3% | −19.2% |
| 2008 | 68.1% | 2.9% | −10.9% |
| 2009 | 69.9% | 10.4% | 3.3% |
| 2010 | 72.0% | 13.9% | 7.4% |
| 2011 | 73.5% | 27.1% | 8.4% |
| 2012 | 76.9% | 8.0% | 2.4% |
| 2013 | 22.0% | 0.8% | 15.9% |
| 2014 | 17.3% | 3.4% | no data |
| 2015 | 57.2% | 54.7% | no data |
| 2016 | 58.1% | 55.7% | 0.4% |
| 2017 | 58.3% | 56.3% | 9.2% |
| 2018 | 55.9% | 49.8% | −22.1% |
| 2019 | 56.1% | 49.6% | −6.7% |
| 2020 | 56.4% | 51.2% | 1.3% |
| 2021 | 51.4% | 48.1% | −2.7% |
| 2022 | 56.4% | 52.4% | 9.7% |
| 2023 | 36.7% | 31.8% | 9.3% |
| 2024 | 57.6% | 52.7% | 8.7% |
| 2025 | 58.9% | 53.6% | 9.9% |
| 2026 | 36.6% | 17.9% | 11.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2007 | −16.9% | −1.6% | −7.2% |
| 2008 | −4.0% | 0.9% | −2.8% |
| 2009 | 1.6% | 3.3% | 1.0% |
| 2010 | 3.4% | 3.2% | 0.9% |
| 2011 | 3.7% | 8.1% | 2.6% |
| 2012 | 2.2% | 4.5% | 0.6% |
| 2013 | 11.1% | 0.2% | 3.6% |
| 2014 | no data | 1.1% | no data |
| 2015 | no data | 29.5% | no data |
| 2016 | 0.4% | 40.9% | 0.3% |
| 2017 | 8.2% | 34.0% | 4.3% |
| 2018 | −24.8% | 25.1% | −11.7% |
| 2019 | −4.5% | 23.5% | −2.5% |
| 2020 | 0.9% | 14.2% | 0.5% |
| 2021 | −1.8% | 11.9% | −1.0% |
| 2022 | 9.0% | 30.5% | 4.7% |
| 2023 | 8.1% | 18.7% | 4.7% |
| 2024 | 7.8% | 30.7% | 4.5% |
| 2025 | 8.7% | 33.1% | 5.7% |
| 2026 | 10.5% | 10.5% | 6.5% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 8 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.